MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NVDA
9. FDXF
10. RKLB

Go back to MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers
(NASDAQ: INKT) Delayed: 11.64 +0.33 (2.92%)
Previous Close $11.31    52 Week High $ 
Open $11.52    52 Week Low $ 
Day High $11.97    P/E N/A 
Day Low $11.10    EPS $ 
Volume 34,559